given the independent activity of each agent , their non-overlapping toxicity profiles , and the absence of cross-resistance , it was hypothesized that concurrent administration of azt and ddc in low doses might be at least as active as either drug given individually at higher doses in the treatment of hiv infection .
C0043474
azt
C0019693
hiv infection